Protagonist Therapeutics, Inc (18) | Collaboration Agreements (2)
- Second Amendment to the Exclusive Janssen License and Collaboration Agreement, dated July 27, 2021, by and between Protagonist Therapeutics, Inc. and Janssen Biotech, Inc (Filed With SEC on November 3, 2021)
- First Amendment to Exclusive License and Collaboration Agreement, by and between Protagonist Therapeutics, Inc. and Janssen Biotech, Inc., dated May 7, 2019 (Filed With SEC on August 7, 2019)
